Orgenesis Inc. Files 8-K: Director/Officer Changes & Financials

Ticker: ORGS · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateAug 19, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, financial-reporting

TL;DR

Orgenesis Inc. filed an 8-K on Aug 19, 2025, detailing board/officer changes and financial exhibits.

AI Summary

Orgenesis Inc. filed an 8-K on August 19, 2025, reporting changes in its board of directors and officers, as well as compensatory arrangements. The filing also includes financial statements and exhibits. The company, incorporated in Nevada, has its principal executive offices in Germantown, MD.

Why It Matters

Changes in a company's board and executive team, along with financial disclosures, can signal shifts in strategy or operational focus that may impact investors.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting changes in directors/officers and financial statements, not indicating immediate significant operational or financial distress.

Key Players & Entities

FAQ

What specific items are being reported in this 8-K filing?

This 8-K filing reports on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, and Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on August 19, 2025.

What is Orgenesis Inc.'s state of incorporation?

Orgenesis Inc. is incorporated in Nevada.

Where are Orgenesis Inc.'s principal executive offices located?

Orgenesis Inc.'s principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.

What is the SIC code for Orgenesis Inc.?

The Standard Industrial Classification (SIC) code for Orgenesis Inc. is 2834, Pharmaceutical Preparations.

Filing Stats: 589 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-08-19 16:30:51

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: August 19, 2025 By: /s/ Vered Caplan Vered Caplan Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing